Organigram Global Inc., a leading licensed producer of cannabis, said proxy advisory firm Institutional Shareholder Services Inc. has recommended shareholders vote in favor of its proposed acquisition of Sanity Group GmbH ahead of a March 30 meeting. ISS cited strong strategic rationale, including increased scale, geographic diversification, and improved cash flow, as well as credible valuation and positive market reaction. The deal includes €113.4 million in upfront consideration, with additional earn-out potential, and is backed by Organigram’s board and its largest shareholder, BT DE Investments Inc., a subsidiary of British American Tobacco, signaling institutional confidence in the transaction.
